SE0000540D0 - New compounds - Google Patents
New compoundsInfo
- Publication number
- SE0000540D0 SE0000540D0 SE0000540A SE0000540A SE0000540D0 SE 0000540 D0 SE0000540 D0 SE 0000540D0 SE 0000540 A SE0000540 A SE 0000540A SE 0000540 A SE0000540 A SE 0000540A SE 0000540 D0 SE0000540 D0 SE 0000540D0
- Authority
- SE
- Sweden
- Prior art keywords
- new compounds
- compounds
- new
- formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, ***e
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/06—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals
- C07D295/073—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals with the ring nitrogen atoms and the substituents separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D475/00—Heterocyclic compounds containing pteridine ring systems
- C07D475/06—Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4
Priority Applications (37)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0000540A SE0000540D0 (sv) | 2000-02-18 | 2000-02-18 | New compounds |
ARP010100628A AR029798A1 (es) | 2000-02-18 | 2001-02-12 | Biarilcarboxamidas, su uso en la manufactura de medicamentos, proceso para la preparacion de estos compuestos, e intermediarios utiles en ese proceso |
SI200130060T SI1259508T1 (en) | 2000-02-18 | 2001-02-15 | Novel biarylcarboxamides |
NZ520094A NZ520094A (en) | 2000-02-18 | 2001-02-15 | Novel biarylcarboxamides |
CNB018049362A CN100345847C (zh) | 2000-02-18 | 2001-02-15 | 新的联芳基甲酰胺 |
SK1179-2002A SK11792002A3 (sk) | 2000-02-18 | 2001-02-15 | Biarylkarboxamidy, spôsob ich prípravy a ich použitie |
CZ20022787A CZ20022787A3 (cs) | 2000-02-18 | 2001-02-15 | Nové biarylkarboxamidy |
DE60100996T DE60100996T2 (de) | 2000-02-18 | 2001-02-15 | Biarylcarboxamide |
EEP200200459A EE05149B1 (et) | 2000-02-18 | 2001-02-15 | Biarlkarboksamiidid, meetod nende valmistamiseks, neid sisaldav ravimkoostis ning nende kasutamine ravis |
HU0301069A HUP0301069A3 (en) | 2000-02-18 | 2001-02-15 | Novel biarylcarboxamides, process for their preparation, pharmaceutical compositions containing them and their use |
MXPA02007543A MXPA02007543A (es) | 2000-02-18 | 2001-02-15 | Biarilcarboxamidas novedosas. |
ES01904770T ES2208556T3 (es) | 2000-02-18 | 2001-02-15 | Nuevas biarilcarboxamidas. |
RU2002118302/04A RU2263114C2 (ru) | 2000-02-18 | 2001-02-15 | Соединения, лекарственные средства, способы лечения, способ получения соединений |
EP01904770A EP1259508B1 (en) | 2000-02-18 | 2001-02-15 | Novel biarylcarboxamides |
PL357565A PL202044B1 (pl) | 2000-02-18 | 2001-02-15 | Nowe biarylokarboksyamidy, ich zastosowanie, sposób wytwarzania biarylokarboksyamidów i związki pośrednie |
AU32594/01A AU782693B2 (en) | 2000-02-18 | 2001-02-15 | Novel biarylcarboxamides |
TR2004/00072T TR200400072T4 (tr) | 2000-02-18 | 2001-02-15 | Novel Biarylcarboxamides Biarylcarboxamide Nouveaux Biarylcarboxamides |
JP2001560205A JP4084570B2 (ja) | 2000-02-18 | 2001-02-15 | 新規なビアリールカルボキサミド |
UA2002075475A UA73540C2 (en) | 2000-02-18 | 2001-02-15 | Diarylcarboxamides |
KR1020027010731A KR100769394B1 (ko) | 2000-02-18 | 2001-02-15 | 신규 비아릴카르복스아미드 |
DK01904770T DK1259508T3 (da) | 2000-02-18 | 2001-02-15 | Hidtil ukendte biarylcarboxamider |
PCT/SE2001/000329 WO2001060821A1 (en) | 2000-02-18 | 2001-02-15 | Novel biarylcarboxamides |
CA002397233A CA2397233A1 (en) | 2000-02-18 | 2001-02-15 | Biarylcarboxamides |
AT01904770T ATE252099T1 (de) | 2000-02-18 | 2001-02-15 | Biarylcarboxamide |
BR0108456-9A BR0108456A (pt) | 2000-02-18 | 2001-02-15 | Composto, uso de um composto, métodos de tratamento ou de profilaxia de distúrbios psicóticos ou distúrbios de deterioração intelectual e de doenças humanas, e ,processo para preparação de um composto |
PT01904770T PT1259508E (pt) | 2000-02-18 | 2001-02-15 | Novos biarilcarboxamidas |
IL15054401A IL150544A0 (en) | 2000-02-18 | 2001-02-15 | Novel biarylcarboxamides |
CO01012482A CO5280046A1 (es) | 2000-02-18 | 2001-02-16 | Agonistas alfa 7 y sus composiciones farmaceuticas |
MYPI20010711A MY123580A (en) | 2000-02-18 | 2001-02-16 | Novel biarylcarboxamides |
US10/123,856 US7001914B2 (en) | 2000-02-18 | 2002-04-15 | Compounds |
ZA200205479A ZA200205479B (en) | 2000-02-18 | 2002-07-09 | Novel biarylcarboxamides. |
BG106977A BG106977A (bg) | 2000-02-18 | 2002-08-02 | Нови биарилкарбоксамиди |
IS6492A IS6492A (is) | 2000-02-18 | 2002-08-08 | Ný bíarýlkarboxamíð |
NO20023917A NO20023917L (no) | 2000-02-18 | 2002-08-16 | Nye biarylkarboksamider |
HK03102250A HK1050007A1 (en) | 2000-02-18 | 2003-03-28 | Novel biarylcarboxamides |
US11/325,787 US7214688B2 (en) | 2000-02-18 | 2006-01-05 | Compounds |
US11/680,930 US7491734B2 (en) | 2000-02-18 | 2007-03-01 | 2-(pyridine-4-yl)-N-(quinuclidin-2-yl)thiazole-4-carboxide nicotinic acetylcholine receptor ligands |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0000540A SE0000540D0 (sv) | 2000-02-18 | 2000-02-18 | New compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
SE0000540D0 true SE0000540D0 (sv) | 2000-02-18 |
Family
ID=20278508
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE0000540A SE0000540D0 (sv) | 2000-02-18 | 2000-02-18 | New compounds |
Country Status (34)
Country | Link |
---|---|
US (3) | US7001914B2 (sv) |
EP (1) | EP1259508B1 (sv) |
JP (1) | JP4084570B2 (sv) |
KR (1) | KR100769394B1 (sv) |
CN (1) | CN100345847C (sv) |
AR (1) | AR029798A1 (sv) |
AT (1) | ATE252099T1 (sv) |
AU (1) | AU782693B2 (sv) |
BG (1) | BG106977A (sv) |
BR (1) | BR0108456A (sv) |
CA (1) | CA2397233A1 (sv) |
CO (1) | CO5280046A1 (sv) |
CZ (1) | CZ20022787A3 (sv) |
DE (1) | DE60100996T2 (sv) |
DK (1) | DK1259508T3 (sv) |
EE (1) | EE05149B1 (sv) |
ES (1) | ES2208556T3 (sv) |
HK (1) | HK1050007A1 (sv) |
HU (1) | HUP0301069A3 (sv) |
IL (1) | IL150544A0 (sv) |
IS (1) | IS6492A (sv) |
MX (1) | MXPA02007543A (sv) |
MY (1) | MY123580A (sv) |
NO (1) | NO20023917L (sv) |
NZ (1) | NZ520094A (sv) |
PL (1) | PL202044B1 (sv) |
PT (1) | PT1259508E (sv) |
RU (1) | RU2263114C2 (sv) |
SE (1) | SE0000540D0 (sv) |
SK (1) | SK11792002A3 (sv) |
TR (1) | TR200400072T4 (sv) |
UA (1) | UA73540C2 (sv) |
WO (1) | WO2001060821A1 (sv) |
ZA (1) | ZA200205479B (sv) |
Families Citing this family (69)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE0000540D0 (sv) * | 2000-02-18 | 2000-02-18 | Astrazeneca Ab | New compounds |
US6486172B2 (en) | 2000-08-18 | 2002-11-26 | Pharmacia & Upjohn Company | Quinuclidine-substituted aryl compounds for treatment of disease |
US6492386B2 (en) * | 2000-08-18 | 2002-12-10 | Pharmacia & Upjohn Company | Quinuclidine-substituted aryl compounds for treatment of disease |
US6492385B2 (en) | 2000-08-18 | 2002-12-10 | Pharmacia & Upjohn Company | Quinuclidine-substituted heteroaryl moieties for treatment of disease |
AU2001282874A1 (en) * | 2000-08-18 | 2002-03-04 | Pharmacia And Upjohn Company | Quinuclidine-substituted aryl moieties for treatment of disease (nicotinic acetylcholine receptor ligands) |
WO2002017358A2 (en) * | 2000-08-21 | 2002-02-28 | Pharmacia & Upjohn Company | Quinuclidine-substituted heteroaryl moieties for treatment of disease (nicotinic acetylcholine receptor antagonists) |
WO2002015662A2 (en) * | 2000-08-21 | 2002-02-28 | Pharmacia & Upjohn Company | Quinuclidine-substituted heteroaryl moieties for treatment of disease (nicotinic acetylcholine receptor antagonists |
EP1311505A2 (en) * | 2000-08-21 | 2003-05-21 | PHARMACIA & UPJOHN COMPANY | Quinuclidine-substituted heteroaryl moieties for treatment of disease ( nicotinic acetylcholine receptor ligands ) |
PE20021019A1 (es) * | 2001-04-19 | 2002-11-13 | Upjohn Co | Grupos azabiciclicos sustituidos |
AR036040A1 (es) | 2001-06-12 | 2004-08-04 | Upjohn Co | Compuestos de heteroarilo multiciclicos sustituidos con quinuclidinas y composiciones farmaceuticas que los contienen |
AR036041A1 (es) | 2001-06-12 | 2004-08-04 | Upjohn Co | Compuestos aromaticos heterociclicos sustituidos con quinuclidina y composiciones farmaceuticas que los contienen |
BR0212101A (pt) | 2001-08-24 | 2004-08-24 | Pharmacia & Up John Company | 7-aza [2.2.1] biciclo-heptanos substituìdos com heteroarila para o tratamento de doenças |
BR0212477A (pt) * | 2001-09-12 | 2004-08-24 | Upjohn Co | 7-aza[2.2.1] bicicloheptanos substituìdos para o tratamento de doenças |
CA2462453C (en) | 2001-10-02 | 2009-07-28 | Pharmacia & Upjohn Company | Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease |
WO2003032897A2 (en) * | 2001-10-16 | 2003-04-24 | Astrazeneca Ab | Azabicyclic compounds for the treatment of fibromyalgia syndrome |
MXPA04003986A (es) * | 2001-10-26 | 2004-07-23 | Upjohn Co | Carboxamidas hetero-biciclicas n-azabiciclico sustituidas como agonistas nachr. |
US6849620B2 (en) | 2001-10-26 | 2005-02-01 | Pfizer Inc | N-(azabicyclo moieties)-substituted hetero-bicyclic aromatic compounds for the treatment of disease |
MXPA04004464A (es) * | 2001-11-08 | 2004-08-11 | Upjohn Co | Compuestos de heteroarilo sustituido con azabiciclo para el tratamiento de enfermedades. |
CA2466344A1 (en) | 2001-11-09 | 2003-05-22 | Pharmacia & Upjohn Company | Azabicyclic-phenyl-fused-heterocyclic compounds and their use as alpha7 nachr ligands |
DE10156719A1 (de) | 2001-11-19 | 2003-05-28 | Bayer Ag | Heteroarylcarbonsäureamide |
DE10162375A1 (de) * | 2001-12-19 | 2003-07-10 | Bayer Ag | Bicyclische N-Aryl-amide |
DE10164139A1 (de) | 2001-12-27 | 2003-07-10 | Bayer Ag | 2-Heteroarylcarbonsäureamide |
WO2003070728A2 (en) * | 2002-02-15 | 2003-08-28 | Pharmacia & Upjohn Company | Azabicyclo-substituted benzoylamides and thioamides for treatment of cns-related disorders |
US6894042B2 (en) | 2002-02-19 | 2005-05-17 | Pharmacia & Upjohn Company | Azabicyclic compounds for the treatment of disease |
CA2476681A1 (en) * | 2002-02-19 | 2003-08-28 | Bruce N. Rogers | Fused bicyclic-n-bridged-heteroaromatic carboxamides for the treatment of disease |
DE10211416A1 (de) * | 2002-03-15 | 2003-09-25 | Bayer Ag | Essig- und Propionsäureamide |
DE10211415A1 (de) * | 2002-03-15 | 2003-09-25 | Bayer Ag | Bicyclische N-Biarylamide |
EP1515967B1 (de) * | 2002-06-10 | 2006-11-02 | Bayer HealthCare AG | 2-heteroarylcarbonsäureamide |
US7176198B2 (en) | 2002-08-01 | 2007-02-13 | Pfizer Inc. | 1H-pyrazole and 1H-pyrrole-azabicyclic compounds for the treatment of disease |
GB0220581D0 (en) * | 2002-09-04 | 2002-10-09 | Novartis Ag | Organic Compound |
PL377777A1 (pl) * | 2002-12-11 | 2006-02-20 | Pharmacia & Upjohn Company Llc | Leczenie chorób połączeniami agonistów receptora alfa 7-nikotynowego i innych związków |
PL378026A1 (pl) * | 2003-01-22 | 2006-02-20 | Pharmacia & Upjohn Company Llc | Leczenie chorób z zastosowaniem pełnych agonistów receptora Ó-7 nACh |
GB0310867D0 (en) * | 2003-05-12 | 2003-06-18 | Novartis Ag | Organic compounds |
US20050129610A1 (en) * | 2003-06-24 | 2005-06-16 | Johns Hopkins University | Imaging agents and methods of imaging alpha7-nicotinic cholinergic receptor |
DE10334724A1 (de) * | 2003-07-30 | 2005-02-24 | Bayer Healthcare Ag | N-Biarylamide |
CA2550847A1 (en) * | 2003-12-22 | 2005-07-07 | Glen Ernst | Nicotinic acetylcholine receptor ligands |
BRPI0417927A (pt) * | 2003-12-22 | 2007-04-17 | Astrazeneca Ab | composto, métodos para o tramento ou a profilaxia de uma doença ou condição, e de distúrbios, e para a indução da cessação do hábito de fumar, composição farmacêutica, e, uso de um composto |
AR049401A1 (es) | 2004-06-18 | 2006-07-26 | Novartis Ag | Aza-biciclononanos |
GB0415746D0 (en) | 2004-07-14 | 2004-08-18 | Novartis Ag | Organic compounds |
GB0424564D0 (en) | 2004-11-05 | 2004-12-08 | Novartis Ag | Organic compounds |
JP2008544982A (ja) * | 2005-06-29 | 2008-12-11 | アストラゼネカ・アクチエボラーグ | アルファ7ニコチン性受容体調節剤としてのチオフェン−2−カルボキサミド誘導体 |
GB0521508D0 (en) | 2005-10-21 | 2005-11-30 | Novartis Ag | Organic compounds |
GB0525672D0 (en) | 2005-12-16 | 2006-01-25 | Novartis Ag | Organic compounds |
GB0525673D0 (en) | 2005-12-16 | 2006-01-25 | Novartis Ag | Organic compounds |
EP2155643B1 (en) | 2007-06-08 | 2016-08-10 | MannKind Corporation | Ire-1a inhibitors |
TW200911808A (en) * | 2007-07-23 | 2009-03-16 | Astrazeneca Ab | Novel compounds |
SA08290475B1 (ar) * | 2007-08-02 | 2013-06-22 | Targacept Inc | (2s، 3r)-n-(2-((3-بيردينيل)ميثيل)-1-آزا بيسيكلو[2، 2، 2]أوكت-3-يل)بنزو فيوران-2-كربوكساميد، وصور أملاحه الجديدة وطرق استخدامه |
TW201031664A (en) | 2009-01-26 | 2010-09-01 | Targacept Inc | Preparation and therapeutic applications of (2S,3R)-N-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)-3,5-difluorobenzamide |
CA2776835A1 (en) | 2009-10-13 | 2011-04-21 | Msd Oss B.V. | Condensed azine - derivatives for the treatment of diseases related to the acetylcholine receptor |
WO2011146511A1 (en) | 2010-05-17 | 2011-11-24 | Envivo Pharmaceuticals, Inc. | A crystalline form of (r)-7-chloro-n-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide hydrochloride monohydrate |
KR101928505B1 (ko) * | 2011-01-28 | 2018-12-12 | 에스케이바이오팜 주식회사 | 피리돈 유도체 및 이를 포함하는 약학적 조성물 |
KR101925971B1 (ko) * | 2011-01-28 | 2018-12-06 | 에스케이바이오팜 주식회사 | 피리돈 유도체 및 이를 포함하는 약학적 조성물 |
GB201111705D0 (en) | 2011-07-07 | 2011-08-24 | Takeda Pharmaceutical | Compounds and their use |
GB201111704D0 (en) | 2011-07-07 | 2011-08-24 | Takeda Pharmaceutical | Novel compounds |
JP6263469B2 (ja) | 2011-07-15 | 2018-01-17 | ノバルティス アーゲー | アザ二環式ジ−アリールエーテルの塩およびその製造方法またはその前駆体の製造方法 |
JO3115B1 (ar) | 2011-08-22 | 2017-09-20 | Takeda Pharmaceuticals Co | مركبات بيريدازينون واستخدامها كمثبطات daao |
AU2013259871A1 (en) | 2012-05-08 | 2014-11-20 | Forum Pharmaceuticals Inc. | Methods of maintaining, treating or improving cognitive function |
GB201209587D0 (en) | 2012-05-30 | 2012-07-11 | Takeda Pharmaceutical | Therapeutic compounds |
WO2014122474A1 (en) | 2013-02-07 | 2014-08-14 | Takeda Pharmaceutical Company Limited | Piperidin-1 -yl and azepin-1 -yl carboxylates as muscarinic m4 receptor agonists |
EP3010900B1 (en) | 2013-06-21 | 2018-01-03 | Takeda Pharmaceutical Company Limited | 1-sulfonyl piperidine derivatives as modulators of prokineticin receptors |
GB201314286D0 (en) | 2013-08-08 | 2013-09-25 | Takeda Pharmaceutical | Therapeutic Compounds |
GB201318222D0 (en) | 2013-10-15 | 2013-11-27 | Takeda Pharmaceutical | Novel compounds |
GB201320905D0 (en) | 2013-11-27 | 2014-01-08 | Takeda Pharmaceutical | Therapeutic compounds |
FI20145054L (sv) * | 2014-01-21 | 2015-07-22 | Tellabs Oy | Nätelement för ett dataöverföringsnät |
TW201613864A (en) | 2014-02-20 | 2016-04-16 | Takeda Pharmaceutical | Novel compounds |
KR101623138B1 (ko) | 2014-10-28 | 2016-05-20 | 한국원자력연구원 | 베타 아밀로이드 플라크 검출 및 알츠하이머 질환 진단 또는 치료용 조성물 |
GB201616839D0 (en) | 2016-10-04 | 2016-11-16 | Takeda Pharmaceutical Company Limited | Therapeutic compounds |
GB201619514D0 (en) | 2016-11-18 | 2017-01-04 | Takeda Pharmaceuticals Co | Novel compounds |
JP2021138648A (ja) | 2020-03-04 | 2021-09-16 | 武田薬品工業株式会社 | 経口固形製剤 |
Family Cites Families (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1416872A (en) * | 1972-03-10 | 1975-12-10 | Wyeth John & Brother Ltd | 4-aminoquinoline derivatives |
FI791491A (fi) * | 1979-05-10 | 1980-11-11 | Kopo Konepohja Oy | Traebitshugg |
FR2529548A1 (fr) * | 1982-07-02 | 1984-01-06 | Delalande Sa | Nouveaux derives de l'amino-3 quinuclidine, leur procede et leur application en therapeutique |
US4605652A (en) * | 1985-02-04 | 1986-08-12 | A. H. Robins Company, Inc. | Method of enhancing memory or correcting memory deficiency with arylamido (and arylthioamido)-azabicycloalkanes |
US4863919A (en) * | 1988-02-01 | 1989-09-05 | A. H. Robins Company, Incorporated | Method of enhancing memory or correcting memory deficiency with arylamido(and arylthiomido)-azabicycloalkanes |
DE69111816T4 (de) * | 1990-08-31 | 1996-08-01 | Nippon Shinyaku Co Ltd | Indolederivate und ihre verwendung als serotonin-antagoniste. |
JPH04247081A (ja) * | 1991-02-01 | 1992-09-03 | Takeda Chem Ind Ltd | 5員複素環酸アミド類 |
SE9904176D0 (sv) | 1999-11-18 | 1999-11-18 | Astra Ab | New use |
SE0000540D0 (sv) * | 2000-02-18 | 2000-02-18 | Astrazeneca Ab | New compounds |
FR2809731B1 (fr) | 2000-05-31 | 2002-07-19 | Sanofi Synthelabo | Derives de 1,4-diazabicyclo-[3.2.2] nonane-pheylisoxazole, leur preparation et leur application en therapeutique |
FR2809732B1 (fr) | 2000-05-31 | 2002-07-19 | Sanofi Synthelabo | DERIVES DE 4(-2-PHENYLTHIAZOL-5-yl)-1,4-DIAZABICYCLO-[3.2.2] NONANE, LEUR PREPARATION ET LEUR APPLICATION ENTHERAPEUTIQUE |
FR2809730B1 (fr) | 2000-05-31 | 2002-07-19 | Sanofi Synthelabo | Derives de 1,4-diazabicyclo[3.2.2] nonanebenzoxazole, -benzothiazole et -benzimidazole, leur preparation et leur application therapeutique |
TW593223B (en) | 2000-06-20 | 2004-06-21 | Merz Pharma Gmbh & Co Kgaa | 1-amino-alkylcyclohexanes as 5-HT3 and neuronal nicotinic receptor antagonists |
US6486172B2 (en) | 2000-08-18 | 2002-11-26 | Pharmacia & Upjohn Company | Quinuclidine-substituted aryl compounds for treatment of disease |
US6492386B2 (en) | 2000-08-18 | 2002-12-10 | Pharmacia & Upjohn Company | Quinuclidine-substituted aryl compounds for treatment of disease |
US6492385B2 (en) * | 2000-08-18 | 2002-12-10 | Pharmacia & Upjohn Company | Quinuclidine-substituted heteroaryl moieties for treatment of disease |
AU2001282874A1 (en) | 2000-08-18 | 2002-03-04 | Pharmacia And Upjohn Company | Quinuclidine-substituted aryl moieties for treatment of disease (nicotinic acetylcholine receptor ligands) |
WO2002015662A2 (en) | 2000-08-21 | 2002-02-28 | Pharmacia & Upjohn Company | Quinuclidine-substituted heteroaryl moieties for treatment of disease (nicotinic acetylcholine receptor antagonists |
WO2002017358A2 (en) | 2000-08-21 | 2002-02-28 | Pharmacia & Upjohn Company | Quinuclidine-substituted heteroaryl moieties for treatment of disease (nicotinic acetylcholine receptor antagonists) |
EP1311505A2 (en) | 2000-08-21 | 2003-05-21 | PHARMACIA & UPJOHN COMPANY | Quinuclidine-substituted heteroaryl moieties for treatment of disease ( nicotinic acetylcholine receptor ligands ) |
DE10045112A1 (de) | 2000-09-11 | 2002-03-21 | Merck Patent Gmbh | Verwendung von Indolderivaten zur Behandlung von Erkrankungen des zentralen Nervensystems |
ATE385497T1 (de) | 2000-12-01 | 2008-02-15 | Neurosearch As | 3-substituierte quinuclidin-derivate und deren verwendung als nikotinischen agonisten |
US20020086871A1 (en) | 2000-12-29 | 2002-07-04 | O'neill Brian Thomas | Pharmaceutical composition for the treatment of CNS and other disorders |
CA2550847A1 (en) * | 2003-12-22 | 2005-07-07 | Glen Ernst | Nicotinic acetylcholine receptor ligands |
US7396830B2 (en) * | 2005-10-04 | 2008-07-08 | Bristol-Myers Squibb Company | Piperazine amidines as antiviral agents |
-
2000
- 2000-02-18 SE SE0000540A patent/SE0000540D0/sv unknown
-
2001
- 2001-02-12 AR ARP010100628A patent/AR029798A1/es unknown
- 2001-02-15 SK SK1179-2002A patent/SK11792002A3/sk unknown
- 2001-02-15 KR KR1020027010731A patent/KR100769394B1/ko not_active IP Right Cessation
- 2001-02-15 PL PL357565A patent/PL202044B1/pl not_active IP Right Cessation
- 2001-02-15 JP JP2001560205A patent/JP4084570B2/ja not_active Expired - Fee Related
- 2001-02-15 HU HU0301069A patent/HUP0301069A3/hu unknown
- 2001-02-15 NZ NZ520094A patent/NZ520094A/en unknown
- 2001-02-15 WO PCT/SE2001/000329 patent/WO2001060821A1/en active IP Right Grant
- 2001-02-15 EE EEP200200459A patent/EE05149B1/xx not_active IP Right Cessation
- 2001-02-15 AU AU32594/01A patent/AU782693B2/en not_active Ceased
- 2001-02-15 TR TR2004/00072T patent/TR200400072T4/xx unknown
- 2001-02-15 ES ES01904770T patent/ES2208556T3/es not_active Expired - Lifetime
- 2001-02-15 CA CA002397233A patent/CA2397233A1/en not_active Abandoned
- 2001-02-15 PT PT01904770T patent/PT1259508E/pt unknown
- 2001-02-15 CN CNB018049362A patent/CN100345847C/zh not_active Expired - Fee Related
- 2001-02-15 AT AT01904770T patent/ATE252099T1/de not_active IP Right Cessation
- 2001-02-15 CZ CZ20022787A patent/CZ20022787A3/cs unknown
- 2001-02-15 EP EP01904770A patent/EP1259508B1/en not_active Expired - Lifetime
- 2001-02-15 RU RU2002118302/04A patent/RU2263114C2/ru active
- 2001-02-15 DE DE60100996T patent/DE60100996T2/de not_active Expired - Fee Related
- 2001-02-15 BR BR0108456-9A patent/BR0108456A/pt not_active Application Discontinuation
- 2001-02-15 UA UA2002075475A patent/UA73540C2/uk unknown
- 2001-02-15 DK DK01904770T patent/DK1259508T3/da active
- 2001-02-15 MX MXPA02007543A patent/MXPA02007543A/es active IP Right Grant
- 2001-02-15 IL IL15054401A patent/IL150544A0/xx unknown
- 2001-02-16 CO CO01012482A patent/CO5280046A1/es not_active Application Discontinuation
- 2001-02-16 MY MYPI20010711A patent/MY123580A/en unknown
-
2002
- 2002-04-15 US US10/123,856 patent/US7001914B2/en not_active Expired - Fee Related
- 2002-07-09 ZA ZA200205479A patent/ZA200205479B/xx unknown
- 2002-08-02 BG BG106977A patent/BG106977A/bg unknown
- 2002-08-08 IS IS6492A patent/IS6492A/is unknown
- 2002-08-16 NO NO20023917A patent/NO20023917L/no not_active Application Discontinuation
-
2003
- 2003-03-28 HK HK03102250A patent/HK1050007A1/xx not_active IP Right Cessation
-
2006
- 2006-01-05 US US11/325,787 patent/US7214688B2/en not_active Expired - Fee Related
-
2007
- 2007-03-01 US US11/680,930 patent/US7491734B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE0000540D0 (sv) | New compounds | |
CY1107634T1 (el) | Φαρμακευτικη συνθεση | |
DOP2001000151A (es) | Derivados de imidazopirimidina y derivados de triazolopimidina. | |
DE60135919D1 (de) | Farnesyl transferase-hemmende 6-heterocyclylmethyl-chinolin und chinazol-derivate | |
CY1106132T1 (el) | Παραγωγα πιπepιδινης ως αναστολεις καναλιου καλιου | |
DE60335359D1 (de) | Phthalazinonderivate | |
NO20031001L (no) | Polyarylkarboksamider nyttige som lipidsenkende midler | |
CY1106247T1 (el) | Θειοφαινο- και θειαζολοσουλφοναμιδες ως αντινεοπλαστικοι παραγοντες | |
CY1113648T1 (el) | Παραγωγα πυριδινονης για θεραπεια αθηροσκληρωσης | |
CY1108738T1 (el) | Θεραπευτικοι παραγοντες χρησιμοι για την αγωγη του πονου | |
CY1113657T1 (el) | Νεα παραγωγα βενζοφαινονης ή αλατα αυτων | |
PT1193270E (pt) | Pirrolobenzodiazepinas | |
EE200300088A (et) | Imidasolo-5-üül-2-anilino-pürimidiinid raku proliferatsiooni inhibitsiooni agensitena | |
BR0214268A (pt) | Aperfeiçoamentos em relação a abrilhantadores ópticos | |
PT1181294E (pt) | Novos derivados e analogos da galantamina | |
ATE235462T1 (de) | Metalloproteinase-inhibitoren | |
ATE411287T1 (de) | Neue metallproteinaseinhibitoren | |
SE9901077D0 (sv) | Novel use | |
ATE333457T1 (de) | Zyklische gmp-spezifische phosphodiesteraseinhibitoren | |
SV2003000981A (es) | Fenil-heterociclil-eteres ref. pcs10973 | |
BRPI0416678A (pt) | pirazolpirimidinas | |
MY128164A (en) | Compounds | |
DE60041001D1 (de) | Substituierte homopiperidylbenzimidazolanaloga als fundusrelaxantien | |
EE200200389A (et) | Imidasooli uued derivaadid | |
EA200600608A1 (ru) | Производные имидазопиридина как ингибиторы индуцируемой no-синтазы |